Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine (WHATT)
Open-label Randomized Controlled Trial for the Effects of Continuous Ethinylestradiol/Levonorgestrel (30/150 μg/Day) Compared With Vitamin E (400 IU/Day) in the Treatment of Menstrually-related Migraine and Migraine During Perimenopause
Sponsor: Erasmus Medical Center
This PHASE3 trial investigates Migraine and Migraine;Menstrual and is currently ongoing. Erasmus Medical Center leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
May 2022 — Jan 2024 [monthly]
Recruiting PHASE3
▶ Show 6 earlier versions
-
Oct 2021 — May 2022 [monthly]
Recruiting PHASE3
-
Mar 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Nov 2019 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE3
-
Aug 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Erasmus Medical Center
- Leiden University Medical Center
- Netherlands Brain Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .